Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1979282 | 1.00 | APOBEC3A (0.34) | APOBEC3AMCOLN3APOBEC3G | |
| SCHEMBL1980784 | 0.81 | APOBEC3A (0.34) | APOBEC3AMCOLN3APOBEC3G | |
| SCHEMBL1980389 | 0.72 | APOBEC3A (0.36) | APOBEC3AMCOLN3APOBEC3G | |
| SCHEMBL1980109 | 0.67 | APOBEC3A (0.36) | APOBEC3AMCOLN3APOBEC3G | |
| SCHEMBL1980110 | 0.67 | APOBEC3A (0.36) | APOBEC3AMCOLN3APOBEC3G | |
| SCHEMBL1979305 | 0.66 | — | — | |
| SCHEMBL6578677 | 0.65 | — | — | |
| SCHEMBL2897760 | 0.60 | — | — | |
| SCHEMBL11859896 | 0.58 | APOBEC3A (0.39) | APOBEC3AMCOLN3APOBEC3G | |
| SCHEMBL20997438 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2513082-B1 | New dioxalane and dioxane derivatives and method for producing same | BAYER CROPSCIENCE AG (DE) | 2013-10-02 | — | — | EP | disclosed |
| US-8222435-B2 | Dioxolane and dioxane derivatives and a process for their preparation | BAYER CROPSCIENCE AG (DE) | 2012-07-17 | — | — | US | disclosed |
| US-20110152531-A1 | Novel Dioxolane And Dioxane Derivatives And A Process For Their Preparation | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152531-A1 | Novel Dioxolane And Dioxane Derivatives And A Process For Their Preparation | ACOX1, CYP4X1, ANTXR2 | APOBEC3A 2664/4885MCOLN3 2992/4885APOBEC3G 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.